Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Genmab says rivals appeal U.S. ruling in patent suit
Reuters
Tuesday, December 6, 2011 - 11:33am
tags:
patents, Genmab, Biogen Idec, Genentech, GSK, Arzerra
False Claims Probe Did Not Stop Off-Label Marketing
Pharmalot
Tuesday, December 6, 2011 - 11:26am
tags:
off-label, False Claims Act, Pfizer, Warner-Lambert, Neurontin
GSK's new R&D culture forces research chiefs to hustle for support
Fierce Biotech
Tuesday, December 6, 2011 - 11:22am
tags:
GSK, R&D
Idenix Pharmaceuticals: Go Short Or Bet Long With The Insiders?
Seeking Alpha
Tuesday, December 6, 2011 - 11:20am
tags:
Idenix
Optimer's DIFICID provides economic value in the treatment of CDAD
Yahoo/Fly on the Wall
Tuesday, December 6, 2011 - 11:15am
tags:
Dificid, Optimer, Clostridium Difficile
Takeda unveils plans for global vaccine business
Pharma Times, UK
Tuesday, December 6, 2011 - 9:25am
tags:
vaccines, Takeda
Samsung, Biogen Idec Agree to Set Up $300 Million Venture
Bloomberg
Tuesday, December 6, 2011 - 9:23am
tags:
Biogen Idec, Samsung, South Korea
Ranbaxy launches generic Caduet in U.S
Yahoo/Reuters
Tuesday, December 6, 2011 - 9:22am
tags:
Caduet, Pfizer, Ranbaxy, generics
A Trading Strategy For 7 Biotech/Healthcare Stocks With Upcoming PDUFA Date
Seeking Alpha
Tuesday, December 6, 2011 - 9:21am
tags:
Alkermes, Amylin, Antares, AstraZeneca, Bristol-Myers Squibb, Merck, Eli Lilly
Merck to Invest $1.5 Billion on Research in China Over 5 Years
Bloomberg
Tuesday, December 6, 2011 - 9:20am
tags:
Merck, R&D, China
Pharmasset Poised to Pay 20% on Gilead Closing in First Quarter: Real M&A
Bloomberg
Monday, December 5, 2011 - 10:14pm
tags:
Pharmasset, Gilead, M&A, PSI-7977, hepatitis C
Solving Biotech's "Asymmetry of Maturity" Challenge
Forbes
Monday, December 5, 2011 - 10:08pm
tags:
biotech
Momenta pays $4.5M for Virdante Pharma assets
Yahoo/AP
Monday, December 5, 2011 - 6:17pm
tags:
Virdante Pharma, Momenta, M&A
XenoPort Parkinson's drug fails in trial
Reuters
Monday, December 5, 2011 - 6:16pm
tags:
Parkinson's Disease, XenoPort, XP21279
Illumina Climbs on Speculation Gene-Analysis Toolmaker Is Takeover Target
Bloomberg
Monday, December 5, 2011 - 6:14pm
tags:
M&A, Illumina, gene analysis
5 High Risk/Reward Biotechs For 2012
Seeking Alpha
Monday, December 5, 2011 - 6:13pm
tags:
ONYX Pharmaceuticals, Vertex Pharmaceuticals, Amarin, Chelsea Therapeutics, Cell Therapeutics
Affymax Jumps Most in 16 Months on FDA Review of Anemia Drug
Bloomberg
Monday, December 5, 2011 - 1:34pm
tags:
Affymax, FDA, anemia, chronic kidney disease, JNJ, Amgen, peginesatide
AZ opens drug portfolio to academic investigators
Fierce Biotech
Monday, December 5, 2011 - 1:32pm
tags:
AstraZeneca
FDA revisits safety of newer birth control drugs
Yahoo/AP
Monday, December 5, 2011 - 1:31pm
tags:
birth control, FDA, Yaz, Bayer, Yasmin, blood clots
Regeneron Drops as Eye Drug Shown Similar to Roche's Lucentis
Bloomberg Businessweek
Monday, December 5, 2011 - 12:28pm
tags:
Roche, Lucentis, Regeneron, Eyela, wet-AMD

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.